Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kinga Żelechowska-Matysiak

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Nanoscale Advances|June 16, 2023
Platinum nanoparticles labelled with iodine-125 for combined "chemo-Auger electron" therapy of hepatocellular carcinomaKamil Wawrowicz, Kinga Żelechowska-Matysiak, Agnieszka Majkowska-Pilip, et al.
Nanomaterials (Basel, Switzerland)|July 17, 2020
Nanoparticles in Targeted Alpha TherapyAgnieszka Majkowska-Pilip, Weronika Gawęda, Kinga Żelechowska-Matysiak, et al.
International Journal of Molecular Sciences|December 11, 2022
Oxidative Status as an Attribute for Selective Antitumor Activity of Platinum-Containing Nanoparticles against Hepatocellular CarcinomaKamil Wawrowicz, Agnieszka Majkowska-Pilip, Marzena Szwed, et al.
Molecules (Basel, Switzerland)|March 29, 2023
Doxorubicin- and Trastuzumab-Modified Gold Nanoparticles as Potential Multimodal Agents for Targeted Therapy of HER2+ CancersKinga Żelechowska-Matysiak, Kamil Wawrowicz, Mateusz Wierzbicki, et al.
Molecular Pharmaceutics|May 30, 2025
Radiobioconjugate of Kadcyla with Radioactive Gold Nanoparticles for Targeted Therapy of HER2-Overexpressing CancersKinga Żelechowska-Matysiak, Kamil Wawrowicz, Mateusz Wierzbicki, et al.
EJNMMI Radiopharmacy and Chemistry|October 11, 2023
Au@<sup>109</sup>Pd core-shell nanoparticle conjugated to trastuzumab for the therapy of HER2+ cancers: studies on the applicability of <sup>109</sup>Pd/<sup>109m</sup>Ag in vivo generator in combined β<sup>-</sup> auger electron therapyNasrin Abbasi Gharibkandi, Kamil Wawrowicz, Agnieszka Majkowska-Pilip, et al.
Molecular Pharmaceutics|August 22, 2023
Improvement of the Effectiveness of HER2+ Cancer Therapy by Use of Doxorubicin and Trastuzumab Modified Radioactive Gold NanoparticlesKinga Żelechowska-Matysiak, Evangelia-Alexandra Salvanou, Penelope Bouziotis, et al.
International Journal of Molecular Sciences|March 29, 2023
<sup>198</sup>Au-Coated Superparamagnetic Iron Oxide Nanoparticles for Dual Magnetic Hyperthermia and Radionuclide Therapy of Hepatocellular CarcinomaNasrin Abbasi Gharibkandi, Michał Żuk, Fazilet Zumrut Biber Muftuler, et al.
Pharmaceutics|April 30, 2021
Hybrid System for Local Drug Delivery and Magnetic Hyperthermia Based on SPIONs Loaded with Doxorubicin and EpirubicinDorota Nieciecka, Joanna Celej, Michał Żuk, et al.
Biomolecules|February 26, 2025
Tailored Iron Oxide Nanoparticles as Potential Cannabinoid Carriers for Anti-Cancer TreatmentJan Taudul, Joanna Celej, Kinga Żelechowska-Matysiak, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nanoscale Advances|June 16, 2023
Platinum nanoparticles labelled with iodine-125 for combined "chemo-Auger electron" therapy of hepatocellular carcinomaKamil Wawrowicz, Kinga Żelechowska-Matysiak, Agnieszka Majkowska-Pilip, et al.
Nanomaterials (Basel, Switzerland)|July 17, 2020
Nanoparticles in Targeted Alpha TherapyAgnieszka Majkowska-Pilip, Weronika Gawęda, Kinga Żelechowska-Matysiak, et al.
International Journal of Molecular Sciences|December 11, 2022
Oxidative Status as an Attribute for Selective Antitumor Activity of Platinum-Containing Nanoparticles against Hepatocellular CarcinomaKamil Wawrowicz, Agnieszka Majkowska-Pilip, Marzena Szwed, et al.
Molecules (Basel, Switzerland)|March 29, 2023
Doxorubicin- and Trastuzumab-Modified Gold Nanoparticles as Potential Multimodal Agents for Targeted Therapy of HER2+ CancersKinga Żelechowska-Matysiak, Kamil Wawrowicz, Mateusz Wierzbicki, et al.
Molecular Pharmaceutics|May 30, 2025
Radiobioconjugate of Kadcyla with Radioactive Gold Nanoparticles for Targeted Therapy of HER2-Overexpressing CancersKinga Żelechowska-Matysiak, Kamil Wawrowicz, Mateusz Wierzbicki, et al.
EJNMMI Radiopharmacy and Chemistry|October 11, 2023
Au@<sup>109</sup>Pd core-shell nanoparticle conjugated to trastuzumab for the therapy of HER2+ cancers: studies on the applicability of <sup>109</sup>Pd/<sup>109m</sup>Ag in vivo generator in combined β<sup>-</sup> auger electron therapyNasrin Abbasi Gharibkandi, Kamil Wawrowicz, Agnieszka Majkowska-Pilip, et al.
Molecular Pharmaceutics|August 22, 2023
Improvement of the Effectiveness of HER2+ Cancer Therapy by Use of Doxorubicin and Trastuzumab Modified Radioactive Gold NanoparticlesKinga Żelechowska-Matysiak, Evangelia-Alexandra Salvanou, Penelope Bouziotis, et al.
International Journal of Molecular Sciences|March 29, 2023
<sup>198</sup>Au-Coated Superparamagnetic Iron Oxide Nanoparticles for Dual Magnetic Hyperthermia and Radionuclide Therapy of Hepatocellular CarcinomaNasrin Abbasi Gharibkandi, Michał Żuk, Fazilet Zumrut Biber Muftuler, et al.
Pharmaceutics|April 30, 2021
Hybrid System for Local Drug Delivery and Magnetic Hyperthermia Based on SPIONs Loaded with Doxorubicin and EpirubicinDorota Nieciecka, Joanna Celej, Michał Żuk, et al.
Biomolecules|February 26, 2025
Tailored Iron Oxide Nanoparticles as Potential Cannabinoid Carriers for Anti-Cancer TreatmentJan Taudul, Joanna Celej, Kinga Żelechowska-Matysiak, et al.
Pageof 2